Navigation Links
Allergan in Medical News

Video: Allergan Announces the LATISSE(TM) Wishes Campaign, Committing $1 Million to The Make-A-Wish Foundation(R)

Register on LATISSE(TM) Web Site to Help Reach Goal IRVINE, Calif., March 27 /PRNewswire-FirstCall/ -- Allergan, Inc. (NYSE: AGN ) hosted a star-studded event last night in Hollywood to launch LATISSE (TM) Wishes , a charitable public awareness campaign designed to help make wishes come...

QLT announces agreement to sell Aczone(R) to Allergan for approximately US$150 million

VANCOUVER, June 9 /PRNewswire-FirstCall/ - QLT Inc. (NASDAQ: QLTI; TSX: QLT) announced today that QLT USA, Inc., its wholly-owned subsidiary, has entered into an asset purchase agreement with Allergan Sales, LLC, a wholly-owned subsidiary of Allergan, Inc. (NYSE: AGN ) to fully divest QLT's w...

Novavax and Allergan Terminate Manufacturing Supply Agreement for Estrasorb

Action allows Novavax to focus on its vaccine business and reduce cash burn ROCKVILLE, Md., Oct. 25 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX ) announced today that it has agreed with Allergan, Inc. to terminate its manufacturing supply agreement for Estrasorb. Estrasorb was previou...

Waging War on Wrinkles: Infini Cosmetic Associates Now Offers Recent FDA Approved Dysport - The Botox Alternative

...agreement with the manufacturer, Ipsen. The addition of Dysport™ to their dermal filler arsenal positions Medic as a threatening opponent to the allergan empire and their line of beauty treatments (Botox® and the Juvederm® - hyaluronic acid gel fillers). BOTOX® Cosmetic is the solution f...

Watson Confirms Filing of Abbreviated New Drug Application for Generic Sanctura XR(R)

...on's trospium chloride extended-release capsules are the generic version of allergan Inc.'s Sanctura XR((R))( )product, which is indicated for the treatment of ...ptoms of urge urinary incontinence, urgency and urinary frequency. allergan filed suit against Watson on July 13, 2009 in the U.S. District Court for t...

Coapt Systems, Inc. Launches Hydrelle(TM) a New, FDA-Approved Dermal Filler with Lidocaine for Significant Wrinkle Correction and Greater Patient Comfort

...eater patient comfort. Proven safe and effective, Hydrelle is also a financially attractive alternative to traditional fillers such as Juvederm(R) by allergan Medical, and Restylane(R) by Medicis Pharmaceutical. Hydrelle has been specifically formulated to deliver rapid results comparable to other hyalu...

Infini Cosmetic Associates Offers Boomer Stimulus Packages to Offset Aging and Help Job Seekers Get a Fresh Start

... to 4 months. Individual results may vary. BOTOX® has gained significant popularity in recent years. As a National Educator for Botox Cosmetic and allergan Corp.(the makers of Botox®), Dr. Hall teaches physicians from all over the country. Dr. Hall has performed more than 5000 injections over the last...

Dr. Daniel Ronel Offers New Permanent Lip Enhancement in New Mexico

...Research Council of America. Because of his combined expertise in pediatrics and plastic surgery, Dr. Ronel is one of 13 national experts selected by allergan to sit on the Breast Implant Research Team, an advisory panel on silicone breast implants. Additionally, Dr. Ronel is a member of the Radiesse Medica...

Digirad Names Two Veteran Healthcare Executives to Board

...Laboratories in 1998. Mr. Malchow has also held executive positions at allergan and American Hospital Supply. At allergan he held several positions including Corporate Operating Committee Member, V...

SkinMedica to Co-Promote ACZONE(R) (dapsone) Gel 5% to Pediatricians in the U.S.

... it has entered into a co-promotion agreement with allergan for ACZONE(R) (dapsone) Gel 5%, a first-in-class ...physicians and patients across the country." allergan will continue to distribute the product, and its d... sales force will continue to promote the product. allergan will book all ACZONE(R) Gel 5% sales and SkinMedic...
Allergan in Medical Technology

ExonHit Therapeutics Expands Strategic Collaboration With Allergan

PARIS, France, January 6 /PRNewswire-FirstCall/ -- - Early Renewal of the Agreement to Extend the Collaboration Until December 2011 - Expansion of the Scope of the Collaboration to Include Antibody Discovery in Ophthalmology - Revised Commercial Terms and Payments to ExonH...

Fort Worth Surgeon Chosen as Investigator in Clinical Trial for Weight-Loss Device

...xas, Feb. 20 /PRNewswire/ -- Adam B. Smith, D.O., FACOS, of Fort Worth LAP-BAND(R) is one of two surgeons in the Dallas/Fort Worth metroplex chosen by allergan Medical for "A Research Study of BioEnterics(R) Intragastric Balloon (BIB) System to Assist in the Weight Management of Obese Subjects," a clinical tr...

Novavax Reports Third Quarter 2007 Financial Results and Progress with Vaccine Development Programs

...l supplies of our VLP vaccine candidates. -- Announced in conjunction with allergan the wind down of manufacturing of the production of Estrasorb (R). Estrasorb (R) was acquired by allergan as a result of their acquisition of Esprit Pharma in October 2007. Som...
Allergan in Biological Technology

Video: Allergan Announces U.S. Food and Drug Administration (FDA) Approval of Latisse(TM) -- First and Only Treatment Approved by the FDA for Hypotrichosis of Eyelashes

New Prescription Product Increases Length, Thickness and Darkness of Eyelashes IRVINE, Calif., Dec. 26 /PRNewswire-FirstCall/ -- Allergan, Inc. (NYSE: AGN ) today announced the U.S. Food and Drug Administration (FDA) has approved LATISSE(TM) (bimatoprost ophthalmic solution) 0.03% as a nove...

Indevus Announces Allergan as New Partner for SANCTURA Brand

Company Enters Into License, Commercialization and Supply Agreement Company to Host Conference Call at 12:30 p.m. Eastern Time, September 19, 2007 LEXINGTON, Mass., Sept. 19 /PRNewswire-FirstCall/ -- Indevus Pharmaceuticals, Inc. (Nasdaq: IDEV ) today annou...

ExonHit Therapeutics: Allergan and ExonHit's First Collaboration Compound to Begin Human Clinical Trials

PARIS, August 28 /PRNewswire-FirstCall/ -- ExonHit Therapeutics, a drug and diagnostic discovery company, today announced that its drug discovery collaboration with Allergan Inc. (NYSE: AGN ), a global speciality pharmaceutical and medical device company, has reached a success milestone. As a...

Seasoned Dermatologist Nissan Pilest of Irvine, CA, Joins SDS Clinical Trials as Clinical Investigator for Dermatology Division

...on their full line of lasers including the top tiered GentleMax laser. Dr. Pilest also trains other physicians in the advanced injection techniques of allergan products Juvederm and Botox, is on the Medical Education Faculty for Bioform's Radiesse long term dermal filler and also is a physician trainer for Re...

Dr. Daniel Ronel Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler

...Research Council of America. Because of his combined expertise in pediatrics and plastic surgery, Dr. Ronel is one of 13 national experts selected by allergan to sit on the Breast Implant Research Team, an advisory panel on silicone breast implants. Dr. Ronel is a member of the Radiesse Medical Education Fa...

WuXi AppTec Welcomes Three Senior Professionals

...brings more than 30 years of rich experiences in preclinical safety assessment and drug development. Dr. Yuan had worked previously in Upjohn, Pfizer, allergan and Vitae Pharmaceutical. Dr. Yuan received a D.V.M. from National Taiwan University and a Ph.D. in Veterinary Pathology from Cornell University . ...

ExonHit Therapeutics Invested Strongly in 2008 for Pivotal 2009 Results

... - Expansion of the strategic collaboration with allergan and extension until end 2011 2008 Key e...estone payment in our strategic collaboration with allergan in addition to the annual R&D payments. ... EHT/AGN 0001, the most advanced compound of the allergan collaboration, continues to make progress and is e...

Beacon Equity Issues Technical Trade Alerts on Drug Manufacturer Stocks: FRX, TEVA, AGN, CEPH, VRTX, ADLR

...eaconEquity.com/m Today's Trade Alerts include: Forest Laboratories Inc. (NYSE: FRX ), Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA ), allergan Inc. (NYSE: AGN ), Cephalon Inc. (Nasdaq: CEPH ), Vertex Pharmaceuticals Inc. (Nasdaq: VRTX ) and Adolor Corp. (Nasdaq: ADLR ). Join th...

David Bagley Joins Histogen as President

...multiple critical diseases, wound care and aesthetic product applications. Most recently, Bagley served as Vice President and General Manager for allergan Medical, Inc. with a focus on operations, technology, global distribution, quality and business disciplines. Prior to this, he held positions with Smi...

MultiVu Video Feed: U.S Food and Drug Administration (Fda) Approves Latisse(TM) --

...o dispensing a prescription medical product. Based on today's FDA approval, allergan expects to launch the product nationwide in the first quarter of 2009. Doct... * Frederick Beddingfield, III, MD, PhD, Chief Medical Officer for allergan Medical and Vice President and Therapeutic Area Head for Dermatology ...
Other Tags
(Date:12/26/2014)... (PRWEB) December 26, 2014 The Biofeedback ... place March 24-28, 2015 in Rome, Italy and is ... includes workshops on a wide variety of ... well as peak performance training in athletes. The scientific ... the world. , Biofeedback monitoring allows clients to see ...
(Date:12/26/2014)... 26, 2014 Pentec Health, Inc. number ... state of Pennsylvania for 2014. The awards program, created ... of its kind in the country. The program is ... Department of Community and Economic Development, the Pennsylvania State ... the Central Penn Business Journal. , Charlie ...
(Date:12/25/2014)... TX (PRWEB) December 26, 2014 This ... state of the global Sterilizers industry with a focus ... on the market status of the Sterilizers manufacturers and ... companies and individuals interested in the industry. This report ... definition, applications and manufacturing technology. In this part, the ...
(Date:12/25/2014)... New York, New York (PRWEB) December 25, 2014 ... of the 2010 DePuy ASR hip recall ( http://www.consumerinjurylawyers.com/DePuy/ ... Liebhard LLP reports. According to an Order issued in ... November 20th, the Court will convene an open conference ... Federal Building and United States Courthouse in West Palm ...
(Date:12/25/2014)... (PRWEB) December 25, 2014 The short film ... was created in honor of a true 9/11 hero, Welles ... film festivals including the 24 hours of Nuremberg International Short ... Bangladesh. , Actress, screenwriter and director Luciana Lagana ... this film together with her husband, Gregory Graham ...
Breaking Medicine News(10 mins):Health News:Final Workshop Line-up Announced for 18th Annual Biofeedback Conference in Rome, Italy 2Health News:Pentec Health Ranks Fourteenth on The Best Places to Work in PA for 2014 2Health News:Pentec Health Ranks Fourteenth on The Best Places to Work in PA for 2014 3Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 2Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 3Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 3Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 2Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 3
(Date:12/22/2014)... 2014  The 2014 Holiday Season may be ... Acuity Market Intelligence reports that the long anticipated ... Acuity forecasts that intensifying demand for smart phones, ... will drive a global market of 2.5 billion ... 2020.   According to Maxine ...
(Date:12/19/2014)... Dec. 18, 2014 Research and Markets ... "Micro Market Monitor: North America Perimeter Security Systems ... http://photos.prnewswire.com/prnh/20130307/600769 The North American ... CAGR of 3.6% from 2014 to 2019. Although the ... Canada is expected to grow ...
(Date:12/19/2014)... LAS VEGAS , Dec. 18, 2014   ... platform built for the post-password and Internet of Things ... additional seed funding. The venture round was led by ... Pantera Capital, Rimrock Venture Partners, VegasTechFund, and others.  LaunchKey ... the new funding to expand its team and bring ...
Breaking Biology News(10 mins):First Season of Holiday Shopping with Mobile Biometric Payments Wraps Up With a Present for Biometrics Industry: A Rosy Forecast for More Than 2 Billion Users of 4.8 Billion Mobile Biometric Devices by 2020 2Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 2Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 3LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3
Other Contents